Connection

Jim Oates to Female

Back to Details
This is a "connection" page, showing publications Jim Oates has written about Female.
Jim Oates
Connection Strength
0.737
Female
  1. Endothelial cells: potential novel regulators of renal inflammation. Am J Physiol Renal Physiol. 2022 03 01; 322(3):F309-F321.
    View in: PubMed
    Score: 0.042
  2. Development of a lupus nephritis suboptimal response prediction tool using renal histopathological and clinical laboratory variables at the time of diagnosis. Lupus Sci Med. 2021 08; 8(1).
    View in: PubMed
    Score: 0.041
  3. Plasma Sphingolipid Profile Associated With Subclinical Atherosclerosis and Clinical Disease Markers of Systemic Lupus Erythematosus: Potential Predictive Value. Front Immunol. 2021; 12:694318.
    View in: PubMed
    Score: 0.040
  4. Lupus serum induces inflammatory interaction with neutrophils in human glomerular endothelial cells. Lupus Sci Med. 2020 10; 7(1).
    View in: PubMed
    Score: 0.038
  5. Race disparity in blood sphingolipidomics associated with lupus cardiovascular comorbidity. PLoS One. 2019; 14(11):e0224496.
    View in: PubMed
    Score: 0.036
  6. Effective Self-Management Interventions for Patients With Lupus: Potential Impact of Peer Mentoring. Am J Med Sci. 2017 06; 353(6):580-592.
    View in: PubMed
    Score: 0.030
  7. Intervention to Improve Quality of life for African-AmericaN lupus patients (IQAN): study protocol for a randomized controlled trial of a unique a la carte intervention approach to self-management of lupus in African Americans. BMC Health Serv Res. 2016 08 02; 16(a):339.
    View in: PubMed
    Score: 0.029
  8. Development of Biomarker Models to Predict Outcomes in Lupus Nephritis. Arthritis Rheumatol. 2016 08; 68(8):1955-63.
    View in: PubMed
    Score: 0.029
  9. At the Bedside: Neutrophil extracellular traps (NETs) as targets for biomarkers and therapies in autoimmune diseases. J Leukoc Biol. 2016 Feb; 99(2):265-78.
    View in: PubMed
    Score: 0.027
  10. A Pilot Study to Determine if Vitamin D Repletion Improves Endothelial Function in Lupus Patients. Am J Med Sci. 2015 Oct; 350(4):302-7.
    View in: PubMed
    Score: 0.027
  11. NADPH oxidase and nitric oxide synthase-dependent superoxide production is increased in proliferative lupus nephritis. Lupus. 2013 Nov; 22(13):1361-70.
    View in: PubMed
    Score: 0.024
  12. Endothelial nitric oxide synthase reduces crescentic and necrotic glomerular lesions, reactive oxygen production, and MCP1 production in murine lupus nephritis. PLoS One. 2013; 8(5):e64650.
    View in: PubMed
    Score: 0.023
  13. Premature atherosclerosis is associated with hypovitaminosis D and angiotensin-converting enzyme inhibitor non-use in lupus patients. Am J Med Sci. 2012 Oct; 344(4):268-73.
    View in: PubMed
    Score: 0.022
  14. Selective cyclooxygenase-2 inhibitor suppresses renal thromboxane production but not proliferative lesions in the MRL/lpr murine model of lupus nephritis. Am J Med Sci. 2011 Feb; 341(2):101-5.
    View in: PubMed
    Score: 0.020
  15. Inducible nitric oxide synthase inhibitor SD-3651 reduces proteinuria in MRL/lpr mice deficient in the NOS2 gene. J Investig Med. 2008 Oct; 56(7):911-9.
    View in: PubMed
    Score: 0.017
  16. Association of serum nitrate and nitrite levels with longitudinal assessments of disease activity and damage in systemic lupus erythematosus and lupus nephritis. Arthritis Rheum. 2008 Jan; 58(1):263-72.
    View in: PubMed
    Score: 0.016
  17. Association of reactive oxygen and nitrogen intermediate and complement levels with apoptosis of peripheral blood mononuclear cells in lupus patients. Arthritis Rheum. 2007 Nov; 56(11):3738-47.
    View in: PubMed
    Score: 0.016
  18. Inducible nitric oxide synthase inhibitors reduce urinary markers of systemic oxidant stress in murine proliferative lupus nephritis. J Investig Med. 2005 Nov; 53(7):347-52.
    View in: PubMed
    Score: 0.014
  19. Nitric oxide induces apoptosis in spleen lymphocytes from MRL/lpr mice. J Investig Med. 2004 Jan; 52(1):62-71.
    View in: PubMed
    Score: 0.012
  20. Nitric oxide synthase 2 promoter polymorphisms and systemic lupus erythematosus in african-americans. J Rheumatol. 2003 Jan; 30(1):60-7.
    View in: PubMed
    Score: 0.011
  21. Loss-of-function variants in SAT1 cause X-linked childhood-onset systemic lupus erythematosus. Ann Rheum Dis. 2022 Dec; 81(12):1712-1721.
    View in: PubMed
    Score: 0.011
  22. Staphylococcus aureus peptidoglycan (PGN) induces pathogenic autoantibody production via autoreactive B cell receptor clonal selection, implications in systemic lupus erythematosus. J Autoimmun. 2022 07; 131:102860.
    View in: PubMed
    Score: 0.011
  23. A Distinct Plasma Microbiome But Not Gut Microbiome in Patients With Systemic Lupus Erythematosus Compared to Healthy Individuals. J Rheumatol. 2022 06; 49(6):592-597.
    View in: PubMed
    Score: 0.011
  24. Up-Regulated Interleukin-10 Induced by E2F Transcription Factor 2-MicroRNA-17-5p Circuitry in Extrafollicular Effector B Cells Contributes to Autoantibody Production in Systemic Lupus Erythematosus. Arthritis Rheumatol. 2022 03; 74(3):496-507.
    View in: PubMed
    Score: 0.011
  25. Phase III/IV, Randomized, Fifty-Two-Week Study of the Efficacy and Safety of Belimumab in Patients of Black African Ancestry With Systemic Lupus Erythematosus. Arthritis Rheumatol. 2022 01; 74(1):112-123.
    View in: PubMed
    Score: 0.010
  26. Camptothecin and Topotecan, Inhibitors of Transcription Factor Fli-1 and Topoisomerase, Markedly Ameliorate Lupus Nephritis in (NZB ? NZW)F1 Mice and Reduce the Production of Inflammatory Mediators in Human Renal Cells. Arthritis Rheumatol. 2021 08; 73(8):1478-1488.
    View in: PubMed
    Score: 0.010
  27. A Link Between Plasma Microbial Translocation, Microbiome, and Autoantibody Development in First-Degree Relatives of Systemic Lupus Erythematosus Patients. Arthritis Rheumatol. 2019 11; 71(11):1858-1868.
    View in: PubMed
    Score: 0.009
  28. Peer approaches to self-management (PALS): comparing a peer mentoring approach for disease self-management in African American women with lupus with a social support control: study protocol for a randomized controlled trial. Trials. 2019 Aug 23; 20(1):529.
    View in: PubMed
    Score: 0.009
  29. Progesterone decreases gut permeability through upregulating occludin expression in primary human gut tissues and Caco-2 cells. Sci Rep. 2019 06 10; 9(1):8367.
    View in: PubMed
    Score: 0.009
  30. Cost-effectiveness of a peer mentoring intervention to improve disease self-management practices and self-efficacy among African American women with systemic lupus erythematosus: analysis of the Peer Approaches to Lupus Self-management (PALS) pilot study. Lupus. 2019 Jul; 28(8):937-944.
    View in: PubMed
    Score: 0.009
  31. My life with lupus: contextual responses of African-American women with systemic lupus participating in a peer mentoring intervention to improve disease self-management. BMJ Open. 2018 11 08; 8(11):e022701.
    View in: PubMed
    Score: 0.008
  32. The SLE-key test serological signature: new insights into the course of lupus. Rheumatology (Oxford). 2018 09 01; 57(9):1632-1640.
    View in: PubMed
    Score: 0.008
  33. Peer-to-Peer Mentoring for African American Women With Lupus: A Feasibility Pilot. Arthritis Care Res (Hoboken). 2018 06; 70(6):908-917.
    View in: PubMed
    Score: 0.008
  34. Antiphospholipid Antibodies and Heart Valve Disease in Systemic Lupus Erythematosus. Am J Med Sci. 2018 03; 355(3):293-298.
    View in: PubMed
    Score: 0.008
  35. Cytokine balance and behavioral intervention; findings from the Peer Approaches to Lupus Self-Management (PALS) project. Hum Immunol. 2017 Sep; 78(9):574-581.
    View in: PubMed
    Score: 0.008
  36. "We Would Still Find Things to Talk About": Assessment of Mentor Perspectives in a Systemic Lupus Erythematosus Intervention to Improve Disease Self-Management, Empowering SLE Patients. J Natl Med Assoc. 2018 Apr; 110(2):182-189.
    View in: PubMed
    Score: 0.008
  37. A population-based approach for implementing change from opt-out to opt-in research permissions. PLoS One. 2017; 12(4):e0168223.
    View in: PubMed
    Score: 0.008
  38. Effect of late modulation of nitric oxide production on murine lupus. Clin Immunol Immunopathol. 1997 Apr; 83(1):86-92.
    View in: PubMed
    Score: 0.008
  39. Rheumatology Informatics System for Effectiveness: A National Informatics-Enabled Registry for Quality Improvement. Arthritis Care Res (Hoboken). 2016 12; 68(12):1866-1873.
    View in: PubMed
    Score: 0.007
  40. SLE-key(?) rule-out serologic test for excluding the diagnosis of systemic lupus erythematosus: Developing the ImmunArray iCHIP(?). J Immunol Methods. 2016 Feb; 429:1-6.
    View in: PubMed
    Score: 0.007
  41. Differential regulation of cell functions by CSD peptide subdomains. Respir Res. 2013 Sep 08; 14:90.
    View in: PubMed
    Score: 0.006
  42. Caveolin-1 regulates leucocyte behaviour in fibrotic lung disease. Ann Rheum Dis. 2010 Jun; 69(6):1220-6.
    View in: PubMed
    Score: 0.005
  43. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial. Arthritis Rheum. 2010 Jan; 62(1):222-33.
    View in: PubMed
    Score: 0.005
  44. Rituximab-responsive cryoglobulinemic glomerulonephritis in a patient with autoimmune hepatitis. J Clin Gastroenterol. 2008 Aug; 42(7):862-3.
    View in: PubMed
    Score: 0.004
  45. Association of the G-463A myeloperoxidase gene polymorphism with renal disease in African Americans with systemic lupus erythematosus. J Rheumatol. 2007 Oct; 34(10):2028-34.
    View in: PubMed
    Score: 0.004
  46. Anti-dsDNA antibody assay: high specificity and sensitivity with a filtration radioassay in comparison to low specificity with the standard ELISA. J Rheumatol. 2007 Apr; 34(4):734-9.
    View in: PubMed
    Score: 0.004
  47. Urine biomarkers predict the cause of glomerular disease. J Am Soc Nephrol. 2007 Mar; 18(3):913-22.
    View in: PubMed
    Score: 0.004
  48. Oral administration of a decaffeinated green tea (Camellia sinensis) extract did not alter urinary 8-epi-prostaglandin F(2 alpha), a biomarker for in-vivo lipid peroxidation. J Pharm Pharmacol. 2005 Oct; 57(10):1365-9.
    View in: PubMed
    Score: 0.003
  49. Distinct PKC isoforms mediate cell survival and DNA synthesis in thrombin-induced myofibroblasts. Am J Physiol Lung Cell Mol Physiol. 2005 Jan; 288(1):L190-201.
    View in: PubMed
    Score: 0.003
  50. Curcumin-induced apoptosis in scleroderma lung fibroblasts: role of protein kinase cepsilon. Am J Respir Cell Mol Biol. 2004 Jul; 31(1):28-35.
    View in: PubMed
    Score: 0.003
  51. Prostaglandin J(2) inhibition of mesangial cell iNOS expression. Clin Immunol. 2001 Mar; 98(3):337-45.
    View in: PubMed
    Score: 0.002
  52. Thrombosis in patients with connective tissue diseases treated with specific cyclooxygenase 2 inhibitors. A report of four cases. Arthritis Rheum. 2000 Aug; 43(8):1891-6.
    View in: PubMed
    Score: 0.002
  53. Inhibition of mesangial cell nitric oxide in MRL/lpr mice by prostaglandin J2 and proliferator activation receptor-gamma agonists. J Immunol. 2000 Feb 01; 164(3):1498-504.
    View in: PubMed
    Score: 0.002
  54. Correlation of serum measures of nitric oxide production with lupus disease activity. J Rheumatol. 1999 Feb; 26(2):318-24.
    View in: PubMed
    Score: 0.002
  55. Co-inheritance of the polymorphic metabolism of encainide and debrisoquin. Clin Pharmacol Ther. 1986 Mar; 39(3):282-7.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.